Seshu Tyagarajan
Chief Technology Officer · Candel Therapeutics, Inc.
- 2024
- Aug 19, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Seshu Tyagarajan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Peter Tak - $3.16M in CADL purchases and sales in the last 12 months
- Paul B. Manning - $3.00M in CADL purchases and sales in the last 12 months
- Francesca Barone - $236K in CADL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Seshu Tyagarajan?
Seshu Tyagarajan is a corporate insider, tracked as Chief Technology Officer of Candel Therapeutics, Inc. (CADL). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Seshu Tyagarajan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Seshu Tyagarajan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($247K) across all tracked filings.
